Skip to main content

Introduction: P2 Receptors

Buy Article:

$63.00 plus tax (Refund Policy)

The current status of ligand gated ion channel P2X and G protein-coupled P2Y receptor subtypes is described. This is followed by a summary of what is known of the distribution and roles of these receptor subtypes. Potential therapeutic targets of purinoceptors are considered, including those involved in cardiovascular, nervous, respiratory, urinogenital, gastrointestinal, musculo-skeletal and special sensory diseases, as well as inflammation, cancer and diabetes. Lastly, there are some speculations about future developments in the purinergic signalling field.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: g protein-coupled p2y receptor; ligand gated ion channel; p2 receptors; purinergic signalling; purinoceptors

Document Type: Review Article

Affiliations: Autonomic Neuroscience Institute, Royal Free and University College, Rowland Hill Street, London NW3 2PF, U.K..

Publication date: 2004-04-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more